Pfizer Ventures Parent: Pfizer
Pfizer Ventures invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances. The firm identifies and invests in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer's pipeline and shape the future of the industry.
Primary contact
235 East 42nd Street
10017 New York
New York
United States
235 East 42nd Street
10017 New York
New York
United States
Key people π§βπ€βπ§
- Barbara Dalton, Ph.D. - Vice President, WWBD / Senior Managing Partner
- Rana Al-Hallaq, Ph.D. - Executive Director, WWBD / Partner
- Michael Baran, MBA, Ph.D. - Executive Director, WRDM / Partner
- Christopher O'Donnell, Ph.D. - Executive Director, WRDM / Partner
- Denis Patrick, Ph.D. - Vice President, WRDM / Managing Partner
- Marie-Claire Peakman, MRPharmS, Ph.D. - Executive Director, WRDM and Principal
Investments πΈ
AgomAb Therapeutics
Developer of growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues
π Ghent, Belgium
Developer of growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues
π Ghent, Belgium
Artios Pharma
Developer of cancer treatments that target DNA Damage Response pathways to selectively kill cancer cells
π Cambridge, United Kingdom
Developer of cancer treatments that target DNA Damage Response pathways to selectively kill cancer cells
π Cambridge, United Kingdom
Last update: November 1, 2022
Disclaimer: We can not guarantee that the information on this page is 100% correct. more